An altered immune response to Epstein-Barr virus in multiple sclerosis -: A prospective study

被引:214
|
作者
Sundström, P
Juto, P
Wadell, G
Hallmans, G
Svenningsson, A
Nyström, L
Dillner, J
Forsgren, L
机构
[1] Univ Umea Hosp, Dept Neurol, Umea, Sweden
[2] Univ Umea Hosp, Dept Virol, Umea, Sweden
[3] Umea Univ, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden
[4] Lund Univ, Malmo Univ Hosp, Dept Med Microbiol, S-22100 Lund, Sweden
关键词
D O I
10.1212/01.WNL.0000130496.51156.D7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To investigate the association between human herpesviruses and multiple sclerosis ( MS), as well as between measles virus and MS. Methods: The authors identified prospectively collected serum samples from 73 MS cases and retrospective sera from 161 MS cases in two population-based serum bank registers. Analyses of IgG antibody responses in cases and matched referents were performed for Epstein-Barr virus (EBV [EBNA-1 and VCA]), human herpesvirus 6 (HHV-6), herpes simplex virus (HSV), varicella zoster virus (VZV), and measles. Results: All cases showed signs of past EBV infection. High activity to EBNA-1 and HHV-6 significantly ( borderline significance for HHV-6) increased the risk for MS in prospective sera. A discrepancy between activities to EBNA-1 and VCA was striking in MS samples collected less than 5 years before relapsing-remitting MS onset, where high activity to EBNA-1 significantly increased, and high VCA activity significantly decreased the risk for MS. There was no support for major causal roles for HSV, VZV, or measles. Conclusion: Individuals who will develop MS exhibit an altered immune response against the EBV virus characterized by a high IgG activity to EBNA-1 in the absence of high activity to VCA, this being most pronounced in the 5-year period preceding MS onset.
引用
收藏
页码:2277 / 2282
页数:6
相关论文
共 50 条
  • [21] Epstein-Barr virus and multiple sclerosis
    Lucas, R. M.
    Hughes, A. M.
    Lay, M-L J.
    Ponsonby, A-L
    Dwyer, D. E.
    Taylor, B. V.
    Pender, M. P.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (10): : 1142 - 1148
  • [22] Epstein-Barr Virus and Multiple Sclerosis
    Houen, Gunnar
    Trier, Nicole Hartwig
    Frederiksen, Jette Lautrup
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [23] Epstein-Barr virus and multiple sclerosis
    Salvetti, Marco
    Giovannoni, Gavin
    Aloisi, Francesca
    CURRENT OPINION IN NEUROLOGY, 2009, 22 (03) : 201 - 206
  • [24] Prospective Study of Infection with Epstein-Barr Virus and Risk of Developing Multiple Sclerosis
    Ascherio, Alberto
    Munger, Kassandra
    O'Reilly, Eilis
    Falk, Kerstin
    Levin, Lynn
    NEUROLOGY, 2009, 72 (11) : A450 - A450
  • [25] Epstein-Barr virus, vitamin D and the immune response: connections with consequences for multiple sclerosis
    Rasheed, Atia
    Khan, Gulfaraz
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [26] Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis
    Cepok, S
    Zhou, D
    Srivastava, R
    Nessler, S
    Stei, S
    Büssow, K
    Sommer, N
    Hemmer, B
    JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (05): : 1352 - 1360
  • [27] Epstein-Barr virus and multiple sclerosis: Cellular immune response and cross-reactivity
    Lindsey, J. William
    Hatfield, Landon M.
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 229 (1-2) : 238 - 242
  • [28] The immune response to Epstein-Barr virus
    Callan, MFC
    MICROBES AND INFECTION, 2004, 6 (10) : 937 - 945
  • [29] Altered immune landscape of cervical lymph nodes reveals Epstein-Barr virus signature in multiple sclerosis
    Sarkkinen, Joona
    Yohannes, Dawit A.
    Kreivi, Nea
    Duernsteiner, Pia
    Elsakova, Alexandra
    Huuhtanen, Jani
    Nowlan, Kirsten
    Kurdo, Goran
    Linden, Riikka
    Saarela, Mika
    Tienari, Pentti J.
    Kekaelaeinen, Eliisa
    Perdomo, Maria
    Laakso, Sini M.
    SCIENCE IMMUNOLOGY, 2025, 10 (104)
  • [30] Epstein-Barr virus reactivation and multiple sclerosis
    Torkildsen, O.
    Nyland, H.
    Myrmel, H.
    Myhr, K. -M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (01) : 106 - 108